Developmental Research Laboratories, Shionogi & Co., Ltd., Futaba-cho, Toyonaka, Osaka, Japan.
Developmental Research Laboratories, Shionogi & Co., Ltd., Futaba-cho, Toyonaka, Osaka, Japan; Toxicogenomics Informatics Project, National Institute of Biomedical Innovation, Asagi, Ibaraki, Osaka, Japan.
Toxicology. 2014 Oct 3;324:43-54. doi: 10.1016/j.tox.2014.07.005. Epub 2014 Jul 19.
Drug-induced liver injury (DILI) is a significant safety issue associated with medication use, and is the major cause of failures in drug development and withdrawal in post marketing. Cytokines are signaling molecules produced and secreted by immune cells and play crucial roles in the progression of DILI. Although there are numerous reports of cytokine changes in several DILI models, a comprehensive analysis of cytokine expression changes in rat liver injury induced by various compounds has, to the best of our knowledge, not been performed. In the past several years, we have built a public, free, large-scale toxicogenomics database, called Open TG-GATEs, containing microarray data and toxicity data of the liver of rats treated with various hepatotoxic compounds. In this study, we measured the protein expression levels of a panel of 24 cytokines in frozen liver of rats treated with a total of 20 compounds, obtained in the original study that formed the basis of the Open TG-GATEs database and analyzed protein expression profiles combined with mRNA expression profiles to investigate the correlation between mRNA and protein expression levels. As a result, we demonstrated significant correlations between mRNA and protein expression changes for interleukin (IL)-1β, IL-1α, monocyte chemo-attractant protein (MCP)-1/CC-chemokine ligand (Ccl)2, vascular endothelial growth factor A (VEGF-A), and regulated upon activation normal T cell expressed and secreted (RANTES)/Ccl5 in several different types of DILI. We also demonstrated that IL-1β protein and MCP-1/Ccl2 mRNA were commonly up-regulated in the liver of rats treated with different classes of hepatotoxicants and exhibited the highest accuracy in the detection of hepatotoxicity. The results also demonstrate that hepatic mRNA changes do not always correlate with protein changes of cytokines in the liver. This is the first study to provide a comprehensive analysis of mRNA-protein correlations of factors involved in various types of DILI, as well as additional insights into the importance of understanding complex cytokine expression changes in assessing DILI.
药物性肝损伤(DILI)是与药物使用相关的重大安全问题,也是药物开发和上市后失败的主要原因。细胞因子是免疫细胞产生和分泌的信号分子,在 DILI 的进展中发挥着关键作用。尽管有许多关于几种 DILI 模型中细胞因子变化的报道,但我们所知,尚未对各种化合物诱导的大鼠肝损伤中细胞因子表达变化进行全面分析。在过去的几年中,我们构建了一个公共的、免费的、大规模的毒理学基因组学数据库,称为 Open TG-GATEs,其中包含了大鼠用各种肝毒性化合物处理后的微阵列数据和毒性数据。在这项研究中,我们测量了总共 20 种化合物处理的大鼠冷冻肝中 24 种细胞因子的蛋白表达水平,这些化合物的数据来自 Open TG-GATEs 数据库的原始研究,并结合 mRNA 表达谱分析了蛋白表达谱,以研究 mRNA 和蛋白表达水平之间的相关性。结果表明,白细胞介素(IL)-1β、IL-1α、单核细胞趋化蛋白(MCP)-1/CC-趋化因子配体(Ccl)2、血管内皮生长因子 A(VEGF-A)和激活调节正常 T 细胞表达和分泌(RANTES)/Ccl5 的 mRNA 和蛋白表达变化之间存在显著相关性,在几种不同类型的 DILI 中。我们还表明,在不同类别的肝毒性剂处理的大鼠肝脏中,IL-1β 蛋白和 MCP-1/Ccl2 mRNA 通常上调,并在检测肝毒性方面表现出最高的准确性。结果还表明,肝 mRNA 变化并不总是与肝内细胞因子的蛋白变化相关。这是第一项提供全面分析各种类型 DILI 相关因素的 mRNA-蛋白相关性的研究,以及进一步深入了解在评估 DILI 时理解复杂细胞因子表达变化的重要性的研究。